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Abstract 
Nutritional strategies play an important role in facilitating peak athletic 
performances and research has shown that a state of physiological ketosis, from 
either a ketogenic diet or ketone supplementation, may have several benefits for 
athletes. These ergogenic properties may stem from the thermodynamic 
advantages ketones possess over other energy substrates as well as their ability 
to preserve glucose stores. Physiological ketosis has also shown improvements in 
cognitive performance, particularly for those suffering from neurological disease. 
The following thesis uses an oral ketone supplement (sodium- and potassium-
based β-hydroxybutyrate) to elevate blood ketone concentrations to assess the 
effects of supplement induced ketosis on exercise metabolism and cycling 
performance (study 1, Chapter 2), as well as its effect on cognitive performance 
in an active population (study two, Chapter 3). As part of study 1, Twelve 
participants took part in a double-blind, placebo-controlled, randomised 
crossover design. The research assessed the effect of supplement-induced 
ketosis on 4 minute all-out cycling performance which followed 90 minutes at 
second ventilatory threshold (VT2). Upon ingestion of a ketone supplement (KET: 
30 ml of Ketoforce; Prototype Nutrition, IL, USA) or placebo (PLA: 3g table salt; 
NaCl), effect size (ES) analysis, revealed an unclear 2.3 ±4.8% (Δ mean ±90% 
Confidence Interval (CI)) change  in power output during a 4-minute maximal 
cycling performance test (4PT) in the KET trial compared to PLA. Therefore no 
substantial performance outcomes came as a result of ketone supplementation 
despite a three-fold increase in blood β-hydroxybutyrate concentration (ES ±90% 
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CI= 3.02 ±0.8; very large) which was accompanied by a 2.2 ±1.9% increase in the 
respiratory exchange ratio (RER) during the submaximal exercise phase (ES = 0.51 
±0.4; moderate). During the 4PT increases in both VO2 (2.4 ±3.3%; ES = 0.24 ±0.3; 
small) and RER (4.3 ±3.3; ES = 0.75 ±0.5, moderate) were evident during the KET 
trial compared to the PLA. Similarly in study 2, the effects of oral ketone 
supplementation on cognitive function were assessed. Using a single blind, 
placebo-controlled design cognitive function was evaluated through five tests 
intended to assess different components of neuro-muscular performance, 
reaction time, processing speed and memory recall: finger tap test (FTT), stroop 
test (ST), reaction time test (RT), monkey-ladder test (MLT) and one-card test 
(OCT). The reliability of each test was also assessed using a test-retest protocol. 
No statistically significant differences (p > 0.05) were observed in cognitive 
function between groups. ES analysis revealed small improvements in the KET 
trial for ST (ES = 0.34 ±0.4) as well as the MLT (ES = 0.34 ±0.4) with either trivial 
or unclear results for FTT, RT and OCT when compared to PLA. In conclusion, 
ingestion of an oral ketone supplement was shown to have no substantial impact 
on human performance as measured through 4-minute cycling performance and 
measures of cognitive function.  
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Thesis overview  
The format of this thesis includes several chapters that are presented in the style 
of individual journal articles, and consequently, some information may be 
repeated. The thesis is comprised of four chapters. Chapter One contains a 
review of literature and introduces the reader to ketones as well as the concept 
of ketone supplementation. Chapter Two focuses on the effects of acute ketone 
supplementation on cycling performance and metabolism, while Chapter Three 
considers the effect of ketones (via supplementation) on cognitive function. Both 
Chapter Two and Chapter Three are presented in the style of individual journal 
articles and appear in the same format that they were submitted to scientific 
journals (currently under review). The final Chapter summarises the overall 
findings from the two experimental studies included in this thesis and provides 
both practical applications and suggested areas for further research. 
 
 
 
 
 
 
 
 
 
 
 
xi 
 
   
Chapter 2: Study 1: The effects of an oral ketone supplement on exercise 
metabolism and cycling performance 
Chapter 1: Literature Review 
Chapter 4: Conclusion 
Figure 1. Schematic of the thesis structure 
Chapter 3: Study 2: The effects of acute ketone supplementation on 
cognitive function. 
1 
 
 
 
 
 
 
 
Chapter 1: 
Literature Review 
 
  
2 
 
Introduction 
Nutritional experts have conflicting views as to the importance of carbohydrates 
as a fuel source for peak athletic performance (Hargreaves, Hawley, & 
Jeukendrup, 2004).  Contrasting views have led more athletes to experiment 
with diets that are very low in carbohydrate and high in fat, opposing some of 
the more traditional diet guidelines. Such a diet, known as a ketogenic diet, aims 
to elevate blood ketone concentrations through strict macro portions (~<50 g 
carbohydrates per day). Ketogenic diets have caught the attention of coaches, 
nutrition experts and scientists as these diets would theoretically allow athletes 
to tap into their relatively unlimited fat stores (~160,000 kJ fat compared to 
~8400 kJ carbohydrate stored in the average male). For this reason, ketogenic 
diets may be of benefit in sports that are long in duration such as cycling, long 
distance/ironman triathlons and long distance running, as well as those where 
weight management is an issue, i.e. boxing, wrestling, rowing and cycling. 
Ketogenic diets have also been shown to aid the health of individuals in various 
disease states and studies on cognitive function may provide further reason for 
the promotion of a ketogenic diet for athletes (Reger et al.; Veech, Chance, 
Kashiwaya, Lardy, & Cahill, 2001).  
A potential limitation of the diet is the depletion of glycogen stores, which has 
been shown to be detrimental to high intensity exercise performance 
(Bergström, Hermansen, Hultman, & Saltin, 1967). To combat this, there have 
been reports of athletes using a relatively novel ketone supplement. The use of 
ketone supplements may provide athletes many of the benefits associated with 
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elevated ketone levels without having to deplete glycogen stores and adhere to a 
strict ketogenic diet.  
Indeed, there has also been speculation that members of the cycling peloton in 
the 2015 Tour de France have been supplementing with ketones to enhance 
their endurance performance (Farrand, 2015). The following review aims to 
analyse current literature concerning the elevation of blood ketone 
concentrations and shed light on a novel supplement now being used by athletes 
as an alternative to a ketogenic diet.  
 
Ketones  
Ketone bodies include three compounds; β-hydroxybutyrate (BHB), the major 
circulating form, acetoacetate and acetone. These compounds are small carbon 
fragments that are always present in the blood, however, their value can be 
increased through fasting, a ketogenic diet, after prolonged exercise or via 
nutritional supplementation (Clarke et al., 2012; Laffel, 1999; Owen et al., 1967). 
Veech (2004) states ketones as worthy of the title “super fuel” for their 
mitochondrial energy generation when compared to other common non-
nitrogenous substrates. In essence, the production of ketones is a survival 
mechanism to produce molecules that mimic glucose from the breakdown of fat. 
The importance of ketones is due to their ability to be utilised as a fuel for the 
brain and without them humans would not survive in times of extreme 
starvation.  
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An increase in blood ketone concentrations >0.5 mmol/L is commonly referred to 
as physiological ‘ketosis’ – mentioned hereon in as ketosis (Krebs, 1966). Its 
name stems from the fact that when blood ketone concentrations are above 0.5 
mmol/L there is a physiological shift in the body’s energy regulation away from 
glucose and towards fat as a primary fuel (Veech et al., 2001). Blood ketone 
readings between 0.5 mmol/L and 5 mmol/L are considered by Veech et al. 
(2001) as optimal for performance, with anything up to 7 mmol/L considered to 
be within the normal range of blood ketone levels (without any pH change) 
resulting from the physiological response of carbohydrate  restriction (Owen et 
al., 1967; Paoli, Bosco, Camporesi, & Mangar, 2015). In the past there has been 
fear amongst health professionals of ketosis as large increases in ketone bodies 
are linked to the potentially fatal diabetic ketoacidosis. Ketoacidosis occurs when 
severe insulin deficiency causes free fatty acids (FFA) to discharge out of adipose 
tissue and undergo transformation into ketone bodies at an uncontrollable rate 
(Veech et al., 2001). In this condition, ketone bodies can reach 25mmol/L in 
blood and the body becomes very acidic which can lead to disorientation or a 
loss of consciousness. Severe cases can produce coma and death (Veech, 2004). 
These high ketone concentrations are only possible with medical conditions and 
not through dietary intervention (Alberti, Johnston, Gill, Barnes, & Orskov, 1978).  
 
Dietary ketosis: conflicting nutritional guidelines for exercise performance 
 
There is conflicting opinion surrounding the role of ketones for exercise 
performance. To date, nutritional guidelines promote the ingestion of 
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carbohydrate prior to, and during intense exercise (Jeukendrup, 2014). It is for 
this reason athletes are routinely advised to ingest large amounts of 
carbohydrates during intensive training and racing. Guidelines for carbohydrate 
intake for athletes range from 5 to 7 g.kg-1 body mass per day for general training 
needs; and 7 to 10 g.kg-1 body mass per day for endurance athletes (Burke, Cox, 
Cummings, & Desbrow, 2001). Jeukendrup (2014) suggests that for optimal 
performance athletes must take in small amounts of carbohydrate for events less 
than 1 hr, 30 g.hr-1 of carbohydrate during training sessions lasting between one 
to two hours, 60 g.hr-1 of carbohydrate for events lasting two to three hours, and 
90 g.hr-1 for exercise of greater duration. However, Bosch, Dennis, and Noakes 
(1993) found carbohydrate loading does not necessarily result in greater 
carbohydrate stores, and excess carbohydrates only result in the storage and 
sparing of fat.  Similarly, carbohydrate ingestion during exercise has been shown 
to slow down the rate of liver glycogen breakdown (Coggan & Coyle, 1991).  
These findings identify the limitations surrounding carbohydrates and ask the 
question of whether the promotion of such large quantities of carbohydrate 
should be advised to fuel peak athletic performances during both training and 
competition. Several researchers dispute the need for carbohydrate to elicit peak 
exercise performance and these conflicting views have begun to reach 
mainstream media’s attention (Lambert, Speechly, Dennis, & Noakes, 1994; 
Manninen, 2004; Phinney, 2004). Opposing those studies favouring low fat/high 
carbohydrate (HC) diets, several studies have found no clear advantage in 
carbohydrate consumption for submaximal endurance performance (Lambert et 
al., 1994; Langfort, Zarzeczny, Pilis, Nazar, & Kaciuba-Uścitko, 1997; Phinney, 
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Bistrian, Evans, Gervino, & Blackburn, 1983). These findings are likely due to the 
marked changes in rates of substrate utilization during prolonged, submaximal 
exercise following a high fat (HF) diet (Costill et al., 1977; Jenkins, Storlien, 
Chisholm, & Kraegen, 1988; Lambert et al., 1994). Lambert et al. (1994) and 
Phinney (2004) even argue that ketogenic diets, once adapted have benefits over 
and above a HC diet, such as their ability to tap into the relatively unlimited fat 
supply, their anti-inflammatory properties and lower blood lactate levels for the 
same given exercise intensity (Forsythe et al., 2008; Phinney, 2004; Zajac et al., 
2014). Similarly, the ingestion of exogenous ketones has the ability to mimic 
several of these metabolic adaptations by increasing blood ketone 
concentrations (Clarke et al., 2012; Veech, 2014).  
 
Ketogenic diet vs. ketone supplementation 
 
When following a ketogenic diet there is an obvious absence of carbohydrate, 
whereby glucose can be synthesised by the breakdown of amino acids and fatty 
acids via a process known as gluconeogenesis (Owen et al., 1967). The body 
adapts to low muscular glycogen stores by increasing fat oxidation during low to 
moderate intensity exercise (Lambert et al., 1994; Phinney et al., 1983; 
Stellingwerff et al., 2006). The limitations of a ketogenic diet may result from the 
previously discussed low muscular carbohydrate stores and the commonly 
accepted degradation of physical performance during high intensity exercise. For 
this reason the interest in ketogenic diets is thought to be due to an up-
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regulation in fatty acid oxidation (Bergström et al., 1967; Cameron-Smith et al., 
2003). The diet is often described as difficult to adhere to due to its strict macro 
nutrient proportions and many find it unpalatable, making it a difficult lifestyle 
decision for athletes (Levy, Cooper, & Giri, 2012). The elevation of cholesterol 
levels, increased risk of dilated cardiomyopathy, as well as kidney issues may also  
be of concern for those following a ketogenic diet (Best, Franz, Gilbert, Nelson, & 
Epstein, 2000; Kielb, Koo, Bloom, & Faerber, 2000). Moreover, the strict nature 
of the ketogenic diet means that it is easy for individuals to fall out of ketosis.  
To overcome many of these complications, nutritional ketone supplements, in 
the form of esters and salts, give athletes the ability to rapidly elevate blood 
ketone concentrations. Ketone supplementation allows individuals to achieve 
ketosis along with its claimed benefits, without having to comply with the strict 
ketogenic diet (Cox & Clarke, 2014; D'Agostino, Dean, Pilla, & Arnold, 2014; 
Veech, 2014). The safety and tolerability of ketone supplements has reported 
minor gastric discomfort. However, it is recommended that blood ketone 
concentrations are monitored to reduce the potential side effects but long term 
studies on the supplements safety are currently lacking (Clarke et al., 2012). 
In theory both endogenous ketones and ketone supplements may spare glycogen 
(Robinson & Williamson, 1980), however supplements may enable athletes to do 
so without affecting glycogen stores. The difference stems from the way 
endogenous ketones are metabolised compared with exogenous ketones during 
ketogenesis and ketolysis.  A diet induced ketosis forces the body to react to low 
glycogen stores by increasing FFA circulation. Upon an increase in FFA the  body 
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produces ketones in the liver via a process known as ketogenesis (Laffel, 1999). 
In contrast, supplements ingested orally enter the gut where they are divided 
and then absorbed through the gut epithelium and monocarboxylate 
transporters (MCT). Ketones via supplementation, then take one of two paths 
into circulation, or undergo first-pass metabolism to ketone bodies in the liver 
(Cox & Clarke, 2014). From here both supplements and endogenously produced 
ketones take the same path. They are released into the blood stream where they 
can be metabolised by extra-hepatic tissue, or transported across the plasma and 
mitochondrial membrane by MCT’s. A set of chemical reactions then allow 
ketones to enter the TCA cycle as acetyl-coA (Manninen, 2004). In these 
circumstances the brain has the ability to derive around two-thirds of its fuel 
from the ketone’s BHB and acetoacetate (Bouteldja, Andersen, Møller, & 
Gormsen, 2014).  
 
Therapeutic applications for the use of ketones 
 
Interestingly, physiological ketosis through both ketone supplementation or a 
ketogenic diet may offer therapeutic benefits (Figure 2) in a variety of different 
disease states (Veech et al., 2001). Studies using ketone bodies have been shown 
to aid neurological health and improve certain metabolic disorders (D'Agostino 
et al., 2013).  
Strong evidence exists for the use of a ketogenic diet to reduce seizure rates in 
those suffering from epilepsy (Kinsman, Vining, Quaskey, Mellits, & Freeman, 
1992; Neal et al., 2008; Patel, Pyzik, Turner, Rubenstein, & Kossoff, 2010; Zupec-
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Kania & Spellman, 2008). In one study of 600 patients following a ketogenic diet, 
it was found that almost one third of patients reported the cessation of seizures, 
another third  reported a significant reduction in the number of seizures 
suffered, while the rest had no effect at all (Kinsman et al., 1992). In this study by 
Kinsman et al. (1992) ketone levels were analysed through urine, such measures 
have been shown to be a poor reflection of blood ketones therefore those who 
did not see improvements may not have elevated ketone concentrations to the 
necessary level. Consequently, one report suggests that blood concentrations of 
about 4 mmol/L are required to see effective improvements in symptoms related 
to epilepsy which is difficult to achieve through diet alone (Gilbert, Pyzik, & 
Freeman, 2000). The difficulty of raising ketone concentrations through a diet 
may explain the lack of improvement for some. The anti- epileptic properties of 
ketones, have been shown to suppress the expression of pro-apoptosis factors 
which strongly link to the enhanced rates of recovery from seizure episodes 
following a ketogenic diet and may explain the improvement for those following 
a ketogenic diet (Hallbook, Ji, Maudsley, & Martin, 2012). 
Kashiwaya et al. (2000) suggests that mild ketosis might also be an effective 
therapy to improve Parkinson’s disease. Ketones added to a culture of neurons 
from the hippocampal cells of embryonic rats seem to block the damage caused 
by the toxin 1-methyl-4-phenylpyridinium, MPP(+).  In this circumstance, damage 
to cellular mitochondrial function is normally evident; however Kashiwaya et al. 
(2000) noted that ketones seemed to prevent the damage from occurring. 
Further studies have also shown that ketones have the ability to protect neurons 
from the effects of oxidative stress by reducing glutamate-induced free radical 
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formation and enhancing mitochondrial respiration in neocortical neurons (Kim 
et al., 2007; Maalouf, Sullivan, Davis, Kim, & Rho, 2007). This mechanism may, in 
part, contribute to the neuroprotective activity of ketones by restoring normal 
function in the face of oxidative stress. 
Other positive results/biomarkers resulting from elevated blood ketone 
concentrattions have been found for those suffering from pathological 
conditions, such as diabetes, polycystic ovary syndrome, acne, cancer and the 
improvement of cardiovascular disease risk factors (Paoli, Rubini, Volek, & 
Grimaldi, 2013; Poff, Ari, Arnold, Seyfried, & D'Agostino, 2014; Veech, 2004; 
Westman, Yancy Jr, Mavropoulos, Marquart, & McDuffie, 2008; Yancy Jr, Foy, 
Chalecki, Vernon, & Westman, 2005; Zhou et al., 2007). These therapeutic 
effects, whilst having no direct implications for exercise performance, suggest 
that ketones should no longer be considered a disadvantaged fuel.   
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Figure 2. The suggested mechanisms for which there exists (a) strong evidence and (b) 
emerging evidence in regards to the therapeutic benefits of a ketogenic diet. 
Obtained from: Paoli, A., Rubini, A., Volek, J. S & Grimaldi,K A. "Beyond Weight Loss: A 
Review of the Therapeutic Uses of very-Low-Carbohydrate (Ketogenic) Diets." European 
Journal of Clinical Nutrition, 67.8 (2013): 789-96.  
 
 
 
 
  
12 
 
Ketones: effect on cognitive performance 
 
There is evidence to suggest that ketosis may have the ability to enhance 
cognitive function. Anecdotally an increase in ketones has been described by 
many to increase alertness and provide a stimulant like effect on the body 
(Brown, 2007). Research conducted thus far has shown improvements in 
cognitive function for those suffering from neurological disease.  
Using an emulsified medium chain tryglicerides (MTri) to elevate blood ketone 
levels, Reger et al. (2004) reported that an increase in cognitive function was 
associated with higher ketone values (p = 0.02) in memory impaired adults. It is 
important to note that, when split into either APOE-ε4  or  APOE-ε4+ genotypes, 
only APOE-ε4 allele showed improvement following MCT administration, 
whereas ε4+ subjects showed little change in performance. This finding may 
demonstrate the individual response to ketones on cognitive performance. 
Similarly Krikorian et al. (2012), using a diet that induced ketosis supplemented 
with MTri, found ketone levels were positively correlated with memory 
performance (r = 0.45, p = 0.04) in those with mild cognitive impairment. These 
findings were put down to the neurocognitive benefit of ketones in conjunction 
with, but also independent of, the effects on insulin - where there was a trend 
toward a moderate relationship between fasting insulin and memory 
performance within the low carbohydrate group. Whilst the majority of current 
literature focuses on individuals suffering from cognitive impairment, the 
findings from the above studies lay the grounds for future research on the ability 
of ketones to improve cognitive performance in healthy individuals.  
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The mechanisms responsible for improved cognitive performance are largely 
unknown and several advantages of ketones may exist. Mechanisms thought to 
enhance cognitive function may be due to the metabolic advantage held by 
ketones and their large anti-oxidant capacity (Veech et al., 2001). In an energy 
deficient state, ketones, over other fuels (including glucose), have been shown to 
be a more efficient fuel, providing a greater energy yield  upon oxidisation (Sato 
et al., 1995). Therefore in conditions of hypoxia ketones may have applications 
for athletes by improving their ability to make better decisions during strenuous 
activity (Veech, 2004). Page et al. (2009) also demonstrated that BHB is 
comparable to glucose in its ability to support synaptic load. Synapse activity is 
necessary to produce complex behaviours and store memories, accordingly a 
reduction in synapse activity has detrimental effects on cognition (Mayford, 
Siegelbaum, & Kandel, 2012; Tampellini et al., 2010). Another theory for 
improved cognitive function comes from the enhancement of gene expression 
that encodes mitochondrial enzymes and energy metabolism in the 
hippocampus, a part of the brain important for learning and memory (Noh et al., 
2004). The effect of ketones on neurodegenerative disease has been heavily 
researched, however little is known about the effects of ketones on cognitive 
performance in healthy individuals. However, the findings from the above 
studies lay the grounds for future research on the ability of ketones to improve 
cognitive performance in healthy individuals.  
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Ketones: effect on exercise performance 
 
To our knowledge, there is no research to have focused on the use of oral ketone 
supplements for exercise performance. All literature directly relating to elevated 
blood ketone concentrations are from a diet-induced ketosis (Table 1). These 
studies have found mixed results, though vastly different methodologies have 
been used. In theory one would assume ketogenic diets to have the greatest 
effect on the aerobic energy system due to the diets sparing effects on glucose 
(Miller, Bryce, & Conlee, 1984). For this reason the majority of research has 
focused on the aerobic system, with just three studies on high intensity exercise 
performance and two studies focussing on strength performance. From earlier 
research regarding ketogenic diets and exercise, several potential benefits to 
elevated blood ketones concentrations have been found. One is that in 
conditions of hypoxia; ketosis may be beneficial due to the higher energy yield of 
ketones and this may translate to better performance at high altitudes, or 
cognitive function during maximal exercise but such claims remain untested 
(Veech, 2004). An additional advantage of utilising ketones during exercise may 
also be due to the reduced inflammation and the reduction of waste products, 
such as blood lactate concentrations (Forsythe et al., 2008; Masino, Kawamura 
Jr, Wasser, Pomeroy, & Ruskin, 2009; Zajac et al., 2014).   
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Ketogenic diets and aerobic exercise 
 
Early research to assess the effects of ketogenic diets on exercise performance, 
showed the diet to be detrimental to performance (Galbo, Holst, & Christensen, 
1979). The research by Galbo et al. (1979) showed that after 4 days of a 
ketogenic diet, participants (n = 7) reduced the time until exhaustion in a running 
test at 70% of VO2 max. Similar findings have been shown in other studies that 
have used shorter adaption periods of 14 days or less (often with carbohydrate 
restoration days). These studies have shown a trend for an increase in fat 
oxidation as well as a decrease in glycogen utilisation but in accordance with 
Galbo et al.’s study, have shown detrimental effects on performance (Burke & 
Hawley, 2002; Galbo et al., 1979; Stellingwerff et al., 2006).  
In accordance to previous work, Phinney et al. (1980) agreed that short term fat 
adaptation decreased performance, but put forward the idea that a longer 
adaption period is necessary for the body to recover after the removal of 
carbohydrate from the diet. These views stem from research where participants 
were found to reduce their time until exhaustion after following a strict 
ketogenic diet for one-week, but improved their performance over time until the 
6 week study concluded (Phinney et al., 1980). Further work has demonstrated 
that elite level cyclists were able to perform equally well after 4 weeks on a low 
carbohydrate, high fat (LCHF) diet when compared to a HC diet in terms of 
VO2max and exercise time until exhaustion (Phinney et al., 1983). Subjects also 
increased fat oxidation, while reducing glucose oxidation and glycogen use after 
the ketogenic diet compared to the control diet. In his research, Phinney et al. 
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(1983) estimated that subject’s blood glucose provided 28% of calories on the 
normal diet and 9% of calories on the ketogenic diet. It is worthwhile to note, the 
variation between participants was so great that only two improved their 
endurance performance substantially (by 57% and 30% respectively) and due to 
the small number of participants in this study, results may have been skewed. 
However the work by Phinney et al. (1983) questions previous views on the 
necessity of carbohydrates for exercise performance, specifically endurance 
exercise, and is unique due to the fact that it used a 4 week adaptation to the 
diet.  The complexity of this research is highlighted through mixed findings and 
so far several studies have found no clear benefit to the use of a ketogenic diet 
to aid endurance performance (Goedecke et al., 1999; Lambert et al., 1994; 
O'Keeffe, Keith, Wilson, & Blessing, 1989).  
 
Ketogenic diets and high intensity exercise 
 
It is well known that as exercise intensity increases the body attains a greater 
proportion of its energy from carbohydrates (Bergman & Brooks, 1999). Even in a 
state of ketosis this has been shown to be the case and this is largely the reason 
for the promotion of carbohydrates during exercise  (Lambert et al., 1994). 
However it has been shown that the glycogen sparing properties of ketones may 
allow glucose to be preserved for times of need and this finding questions 
several theories for carbohydrate loading (Robinson & Williamson, 1980). Studies 
that have included high intensity intervals as part of their performance 
assessment are currently limited, but demonstrate conflicting results.  
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Recent research by Rhyu and Cho (2014) using a parallel group design on trained 
taekwondo athletes found a significant improvement in 2000 m running 
performance after a similar weight loss in both diets. Positive effects on 
inflammatory cytokines where also evident after 3 weeks on a ketogenic diet 
compared with a normal diet (Iinterleukin-6, Interferon-γ, tumor necrosis factor-
α). In the same study Rhyu and Cho (2014) found no difference in performance 
between groups in 100 m run time and Wingate cycling power output. Sawyer et 
al. (2013) had comparable findings in strength trained men (n = 16) and women 
(n = 15) where average power surprisingly increased from (811 ± 28W vs 850 ± 
31W; mean ± SD for HC vs LC respectively) following a 30 second Wingate 
assessment  after 7 days of a LC  diet, however the increase was not considered 
significant. Similarly Lambert et al. (1994) reported that high intensity cycling 
(85% of peak power output unitl exhaustion) did not decline after two weeks 
following a ketogenic diet. A recent study by Zajac et al. (2014) revealed 
conflicting results during a 15min all-out time-trial following 90 min of 
submaximal exercise in 8 trained off-road cyclists. Zajac et al. (2014) found a 
decrease in high intensity exercise performance (p = 0.04) from 362 ± 16W to 
350 ± 15W (mean ± SD) after the ketogenic trial. Before conclusions can be 
made, more trials are necessary to understand the mechanisms and factors 
responsible for the mixed findings of a ketogenic diet on high intensity exercise. 
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Ketogenic diets and strength performance 
 
Only two peer reviewed studies have focused on athletic strength performance 
following a ketogenic diet. Research by Paoli et al. (2012) found no strength 
difference between gymnast’s on a ketogenic diet compared to their ‘normal’ 
western diet. The study noted decreases in body weight and an increase in lean 
(muscular) body mass percentage occurred whilst following the ketogenic diet. 
The performance parameters for the different diets were all body weight 
exercises (hanging straight leg raise, ground push up, parallel bar dips, pull up, 
squat jump, countermovement jump, and 30 second continuous jumps). While 
the study claims no strength loss when on a ketogenic diet, the correct claim may 
be that there is no difference in power to weight ratio’s between those on a 
ketogenic diet compared to their normal western diet. Using strength trained 
athletes Sawyer et al. (2013) reported similar findings in regards to max strength. 
Significant increases in performance were evident in the dynamometry handgrip, 
vertical jump and max squat. It is important to note research by  both Sawyer et 
al. (2013) and Paoli et al. (2012) increased protein intake while on the ketogenic 
diet which can take one out of ketosis due to  the insulin response of protein and 
its role in gluconeogenisis (Floyd Jr, Fajans, Conn, Knopf, & Rull, 1966), however with 
the intensity of training during the experimental trial, it is likely the diet induced 
a state of ketosis. Needless to say, current literature suggests that strength is not 
compromised when following a diet very low in carbohydrates.  
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Ketogenic diets and weight loss 
 
Maintaining optimal body weight is important for many athletes to achieve 
success in their sport, and therefore a desirable weight can be difficult to 
achieve. Such reasons for athletes to reduce weight are often due to the need for 
a high power to weight ratio, or to make certain weight divisions. It is not 
uncommon for athletes in these situations to resort to rapid weight loss 
techniques or diets extremely low in energy. Such ‘crash’ diets can result in a loss 
of lean body mass and can impair physical performance (Turocy et al., 2011).  
Studies have found very low carbohydrate/ketogenic diets to have better results 
for weight loss when compared to other diets higher in carbohydrate (Bazzano et 
al., 2014; Bueno, de Melo, de Oliveira, & da Rocha Ataide, 2013; Johnstone, 
Horgan, Murison, Bremner, & Lobley, 2008; Sondike, Copperman, & Jacobson, 
2003; Stern et al., 2004). As such these diets may hold benefits for sports where 
weight control is important. The anti-obesity characteristics of ketone 
supplements have also demonstrated positive the mechanisms responsible for 
the weight loss is thought to be from a reduction in voluntary food intake and 
increase in resting energy expenditure (Clarke et al., 2012; Srivastava et al., 
2012). In regards to a ketogenic diet, prior research has shown that if an 
adaptation period of at least two weeks is considered, no decrease in 
performance should be observed (Rhyu & Cho, 2014). Therefore a ketogenic diet 
may be a viable route for weight loss without any negative effects on 
performance (Paoli et al., 2015; Paoli et al., 2012).  
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If an athlete is looking to put on mass then evidence has shown that ketogenic 
diets will make this difficult due to the diets blunting effect on the IGF-
1/AKT/mTOR pathway, therefore reducing the possibility of gaining muscle mass 
despite energy sufficiency (Sandri et al., 2013). Possible theories behind the 
effectiveness of ketogenic diets for weight loss include: a decreased appetite 
(Paoli, 2014); increased fat oxidation and reduced lipogenesis; a lower 
respiratory exchange ratio which could indicate better efficiency from the 
increased oxidisation of fats (Phinney et al., 1983); and the thermic effect of the 
ketogenic diet as well as the increased energy requirement from 
gluconeogenesis (Veech, 2004). 
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Table 1.  Effect of low carbohydrate/high fat (LCHF) diet on exercise performance. 
Author Design Duration of 
Adaptation 
Period 
Macronutrient 
Proportions 
No. of 
Participants 
Sport Training 
Status 
Testing Protocol Performance 
Outcome (mean) 
Performance 
Effect 
Galbo et al. 
(1979) 
Crossover 4 days 
Fat= 76% 
CHO= 10% 
7 Running Trained 
70% VO2max until 
exhaustion 
HF:64 min 
HC:106 min 
negative 
Phinney et al. 
(1980) 
Within 
subject 
design 
6 weeks 
1.2g 
protein.kg.day 
6 Walking Untrained 
75% of VO2max until 
exhaustion 
 
HF: 249 ± 28 min 
Baseline diet – 
168 ± 26 min 
 
positive 
Phinney et al. 
(1983) 
Crossover 
design 
4 weeks 
(80% fat, 15% 
protein, <2% 
carbs) 
5 Cycling 
Well-
trained 
62-64% of VO2max 
until exhaustion 
 
HF: 151 ± 25 min 
HC: 147 ±14 min 
 
positive 
O'Keeffe et al. 
(1989) 
Crossover 
design 
1 week <25% CHO 7 Cycling 
Highly-
trained 
80% VO2max until 
exhaustion 
HF:60±12 min 
HC:113±2min 
negative 
Lambert et al. 
(1994) 
Crossover 
design 
2 weeks 
Fat=70% 
CHO=7% 
5 Cycling Trained 
 
85% PPO until 
exhaustion (HIE) + 
50% PPO until 
exhaustion (MIE) 
 
HF diet - MIE=79 
min 
HC diet- MIE= 
42.5 min 
MIE = positive 
 
HIE = no effect 
Goedecke et 
al. (1999) 
 
Parrallel 
group 
design 
15 day 
HF Group 
Fat=69%, 
CHO=19% 
HC group 
CHO=53% 
16 
(8 control,8 
HF) 
Cycling Trained 
150 min @70% 
VO2peak  + 40 km TT 
HF:69.3±2.7min to 
63.4 ±1.9 min 
HC:69.9 ± 2.3min 
to 65.6 ± 2.3min 
No effect 
Abbreviations: HF = high fat; HC = high carbohdrate; CHO = carbohydrate; LCHF = low carbohydrate, high fat;  HIE = high intensity exercise; MIE =moderate intensity 
exercise; PPO = peak power output, TT = time-trial. 
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Table 1. Effect of low carbohydrate/high fat (LCHF) diet on exercise performance (cont’d). 
Author Design 
Duration of 
Adaptation 
Period 
Macronutrient 
Proportions 
No. of 
Participants 
Sport 
Training 
Status 
Testing Protocol 
Performance 
Outcome 
(mean) 
Performance 
Effect 
Paoli et al. 
(2012) 
Within 
subject 
design 
1 month 
Fat=54.8±6.0% 
CHO= 4.5±0.5% 
8 Gymnastics Elite 
Various body 
weight exercises 
No significant 
change 
No strength 
loss 
Sawyer et 
al. (2013) 
Within 
subject 
design 
1 week 
HF Group 
Fat=54%, 
CHO=5% 
HC group 
CHO=41% 
16 men 
15 women 
Strength 
Trained 
Trained 
 
-Various strength 
exercises 
-Wingate anaerobic 
test 
 
 
Significant 
improvements 
in handgrip, 
vertial jump, 
max squat 
 
No strength 
loss 
Zajac et al. 
(2014) 
Crossover 
design 
1 month 
HF=70% Fat, 15 
CHO 
8 Cycling 
Well-
trained 
Day 1- Incremental 
step test 
Day 2- 105min (90 
min@85%LT,15 
min@ 115%LT) 
 
n/a 
MIE = positive 
HIE = negative 
Rhyu and 
Cho (2014) 
Crossover 
design 
3 weeks 
HF Group 
Fat=55%, 
CHO=4.3% 
HC group 
Fat=30%, 
CHO=40% 
16 
(10 control, 
10 HF) 
Taekwondo Trained 
2,000 m sprint, 
Wingate test, grip 
force, back muscle 
strength, sit-up, 
100 m sprint, 
standing broad 
jump, single leg 
standing 
Significant 
improvement 
between trials 
in 2000 m run, 
No significant 
improvements 
in other 
assessments. 
HIE = 
positive/no 
change 
No strength 
loss 
Abbreviations: HF = high fat; HC = high carbohdrate; CHO = carbohydrate; LCHF = low carbohydrate, high fat;  HIE = high intensity exercise; MIE =moderate intensity 
exercise; PPO = peak power output, TT = time-trial. 
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Limitations and future directions  
Results from literature regarding elevated blood ketone concentrations and its 
effect on exercise performance are not unanimous. Reasons for this may be due 
to a large majority of studies not monitoring blood ketone concentrations, and 
although claimed as LCHF or ketogenic, they may not have induced a state of 
physiological ketosis. Another limitation to the above studies is their relatively 
small sample sizes, with the majority of studies only including < 8 subjects. From 
these studies individual responses to a ketogenic diet varied greatly which may 
have skewed results. Future work should attempt to take into account the 
possibility of responders and non-responders, and look to identify possible 
characteristics between these groups. The fact that athletes are already 
rumoured to be using exogenous ketone supplementation highlights the need 
for future research to understand the effects of the supplement on athletic 
performance. Research in the field may also help to improve our current 
knowledge regarding a diet induced ketosis. 
 
Conclusion 
Currently the effects of ketones on exercise performance are debated and 
research demonstrates conflicting opinions over the importance of carbohydrate 
to fuel athletic performance. The amount of carbohydrates required for 
performance, as well as general health, needs further attention and clarification. 
It can be concluded that a negative impact on performance can be seen when a 
ketogenic diet is followed for a short duration (<14days), however, positive 
 24 
 
results are generally shown from literature using a longer adaptation period 
(Lambert et al., 1994; Phinney et al., 1983). Upon adapting to a ketogenic diet, 
the current review of literature suggests that several performance benefits may 
be seen in athletes taking part in aerobic exercise and/or those looking to reduce 
weight. The endurance benefits when following a ketogenic diet are likely to be 
due to the thermodynamic advantage of ketones over other nutritional 
substrates as well as the diets ability to alter metabolic economy through 
increased fat oxidisation and utilisation, resulting in glycogen sparing. The use of 
a ketogenic diet for weight reduction has confounding evidence but the exact 
mechanisms for the diets effectiveness are a topic of debate (Bueno et al., 2013).  
Further research is needed to understand the effect of ketone supplements on 
both cognitive and exercise performance. Current literature demonstrates 
positive findings on cognitive performance in those suffering from 
neurodegenerative disease, but the role of ketones to enhance cognitive 
performance in healthy subjects is yet to be researched.  
To our knowledge, currently no literature exists on the use of exogenous ketone 
supplementation and exercise performance. However, research in other fields 
gives evidence to suggest that the ingestion of a ketone supplement will likely 
alter an athlete’s metabolic efficiency due to the high energy yield of ketones, 
but until experiments are conducted such claims remain unknown. Studies using 
nutritional ketone supplements may be useful to help fill the current knowledge 
gaps that exist in regards to fuel utilisation strategies for athletes. Research on 
the topic is of great importance due to claims that the supplement is already 
 25 
 
being uses by professional athletes despite little being known about its benefits 
or limitations.  
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Chapter 2:  
Study 1: The effects of an oral ketone 
supplement on exercise metabolism and 
cycling performance 
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Abstract 
The purpose of the present study was to examine the effects of an oral ketone 
supplement on exercise metabolism and cycling performance. Using a double-
blind, placebo-controlled, randomised, crossover design, 12 highly-trained 
cyclists (mean ± SD: age; 35 ± 8 y, mass; 74.5 ± 7.6 kg, VO2peak; 68.0 ± 6.7 ml.min
-
1.kg-1) were supplemented with either 60 ml of an oral ketone supplement (KET: 
sodium- and potassium-based β-hydroxybutyrate; BHB) or a placebo formula 
(PLA: table salt; NaCl). Trials were performed on a cycle ergometer where 
participants cycled at a submaximal intensity (80% VT2) for 90-minutes, followed 
by a 4-minute maximal cycling performance test (4PT). During the work bout, the 
metabolic effects of the ketone supplement or placebo were assessed. Power 
output in the 4PT was 2.3 ±4.8% (Δ mean ±90% CI) greater in the KET (364 ± 58 
W) vs. placebo trial (355 ± 46 W) and associated with an unclear effect on 
performance. Ingestion of the ketone supplement increased blood BHB 
concentrations more than two-fold compared to placebo (Effect Size (ES) = 3.02 
±0.8; very large). The increased BHB concentration was accompanied by a 2.2 
±1.9% increase in the respiratory exchange ratio (RER) during the submaximal 
exercise phase (ES = 0.51 ±0.4; moderate) and 4.3 ±3.3% increase during the 4PT 
(ES = 0.75 ±0.6; moderate). Submaximal VO2 did not differ between trials, 
however, VO2 was 2.4 ±3.3% greater during the 4PT phase in the ketone trial (ES 
= 0.24 ±0.3; small). In conclusion, ketone supplementation altered BHB 
concentrations, RER and VO2 values during exercise, but had an unclear impact 
on 4-minute cycling performance. 
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Introduction 
Low carbohydrate ketogenic diets increase blood ketone concentration levels 
and have the potential to enhance energy provision to working muscles for 
prolonged exercise performance (Cox & Clarke, 2014). However, the personal 
discipline required to achieve nutritional ketosis, by consuming less than ~50 g of 
carbohydrate per day, may limit its application in many athletes.  Moreover, the 
inherent low carbohydrate consumption levels required to achieve ketosis have 
the potential to reduce an athlete’s ability to perform high-intensity exercise 
(Havemann et al., 2006).  
The majority of research examining fuel usage during exercise performance has 
failed to consider the role that ketones may have as a contributing substrate to 
the total energetic contribution. Ketones (acetone, acetoacetate, and β-
hydroxybutyrate) are high efficiency substrates. For example, bomb-calorimetry 
work has shown that β-hydroxybutyrate (BHB) will generate 31% more energy 
per carbon molecule (C2) than pyruvate (243.6 kcal/mole vs 185.7 kcal/mole, 
respectively). This highlights the substrate’s potential to provide more potential 
energy to the electron transport chain (Veech, 2004). Similarly, the efficiency of 
ketones (hydraulic work/energy from O2 consumed) have been demonstrated in 
the isolated perfused rat heart (Sato et al., 1995).  These authors showed that 
the addition of ketone bodies (4 mmol/L BHB plus 1 mmol/L acetoacetate) to 10 
mmol/L of glucose increased hydraulic work of the heart by ~25%, while the 
combination of insulin and ketones to the glucose increased efficiency by ~36% 
(Sato et al., 1995). Therefore, in theory oral ketone supplementation has the 
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potential to increase energy production in active skeletal muscle, either by 
reducing the VO2 required during submaximal exercise, by eliciting enhanced 
energy production for a given VO2 during maximal exercise, or a combination of 
both. The superior fuel efficiency of ketone substrates compared to glucose and 
its derivatives goes beyond the glycolytic pathway, and may be explained by two 
steps in the mitochondrial synthesis of ATP (Veech, 2004). As ketones are more 
reduced than pyruvate, a subsequent  reduction in the mitochondrial NAD 
couple, and oxidation of the mitochondrial co-enzyme Q couple, results in an 
increased electron transport chain redox span, creating a larger ΔG’ATP and 
resultant ATP generation (Cox & Clarke, 2014; Sato et al., 1995; Veech et al., 
2001). Additionally, ketone bodies have been shown to act as signals that inhibit 
glucose and glycogen metabolism (Cahill Jr, 1976; Kashiwaya et al., 1994; 
Robinson & Williamson, 1980). The presence of ketone bodies therefore has the 
potential to spare carbohydrate stores during prolonged exercise, and aid 
subsequent high-intensity performance in sports like road cycling or triathlon 
(Lambert et al., 1994; Phinney et al., 1983).  
While always present in the blood (at very low levels), blood ketone 
concentrations typically only rise in response to low blood glucose levels, such as 
during fasting, through dietary carbohydrate restriction (i.e., low carbohydrate 
ketogenic diets), or after prolonged exercise. In attempt to induce physiological 
ketosis, without the challenges associated with diet and exercise manipulation, a 
recently produced synthetic ketone supplement may offer the ability to rapidly 
induce ketosis (Veech, 2014). To our knowledge, we are unaware of research 
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that has examined the effect of such supplementation on exercise metabolism 
and performance in athletes. Therefore, the purpose of the current study was to 
assess the effects of an oral ketone supplement versus placebo on exercise 
metabolism over 90 minutes’ submaximal cycling, and subsequent all-out 4-min 
exercise performance in highly-trained cyclists.  
 
Methods 
 
Participants 
Twelve-highly trained male cyclists (mean ± SD: age, 35 ± 8 y; mass, 74.5 ± 7.6 kg; 
VO2peak, 68.0 ± 6.7 ml.min
-1.kg-1) volunteered to participate in this study. All 
testing took place during the competitive phase of the New Zealand cycling 
season where participants raced at either professional, A or B-grade level. 
Following an explanation of all procedures, risks and benefits, each participant 
gave their written informed consent to partake in the study, which was approved 
by the institution’s Human Research Ethics Committee.  
 
Experimental design 
The study implemented a double-blind, placebo-controlled, randomised, 
crossover design that required participants to visit the laboratory on three 
separate occasions. Prior to taking part in the study, participants were required 
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to refrain from taking any nutritional supplements in the 4 weeks preceding the 
study, as well as during the course of the experiment. Participants were asked to 
document their food intake via a food diary and were instructed not to eat within 
the 2.5 h period before the test, and to repeat their diet in the 48 h period prior 
to each testing session. In the 24 h preceding each trial, participants were asked 
to refrain from strenuous activity and abstain from consuming caffeine on the 
day of the test. On the first visit to the laboratory, participants performed an 
incremental VO2 peak test on their own bicycle attached to a Cyclus II ergometer 
(RBM elektronik-automation GmbH, Leipzig, Germany), where power output 
commenced at 150 W, and increased by 40 W every 4 min until volitional 
exhaustion. Immediately following the progressive exercise test, a familiarisation 
experimental trial was performed (described subsequently).  
 
Exercise testing 
The experimental trials, shown in Figure 3, were conducted on a Wattbike cycle 
ergometer (Wattbike Ltd, Nottingham, UK), set-up to replicate each participant’s 
own bicycle.  The 4-minute maximal performance test (4PT) on a Wattbike has 
been shown to be reliable for testing highly-trained athletes in a laboratory 
setting, with a test-retest coefficient of variation of ~2.7%  (Driller et al., 2014). 
For each experimental trial, participants cycled for 90 min at 80% of their second 
ventilatory threshold (VT2); referred hereafter as submaximal exercise), prior to a 
4PT, separated by 2 min passive rest. During the 90 min submaximal cycling 
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phase, participants were asked their rating of perceived exertion (RPE) every 15 
min (Borg, 1982). 
 
Ketone supplementation  
Twenty minutes prior to the trial, participants ingested either a ketone 
supplement (KET: 30 ml of Ketoforce; Prototype Nutrition, IL, USA) or placebo 
(PLA: 3g table salt; NaCL), diluted with 100 ml of sugar-free lemonade. A second 
dose of ketone supplement or PLA (as described) was ingested at the halfway 
point (45 min) during the 90 min submaximal cycling phase. 
 
Blood sampling 
Finger-tip blood samples were taken to assess blood glucose and blood BHB 
levels using a Freestyle Optium Blood Glucose Monitoring System (Abbot 
Diabetes Care, Oxon, UK). Blood lactate was measured using a Lactate Pro 2 
Analyser (Arkray KDK, Shiga, Japan) alongside blood glucose and BHB measures 
at the end of the 90 min submaximal cycling test and 4PT.   
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Figure 3. Experimental trial - timeline of events. 
Abbreviations: KET= blood BHB concentration; GLU = blood glucose concentration; LA = blood lactate concentration. 
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Statistical analysis 
Data are reported as means ± SD unless otherwise stated. Magnitude-based 
inferences were used to identify practically substantial differences between trials 
for each physiological and performance response during the experimental trials 
via analysis of log-transformed values, to reduce the bias arising from non-
uniformity of error. Ratings of perceived exertion were analysed without log 
transformation. To make inferences about the likely range of the true effect, the 
uncertainty in the effect was expressed as ±90% confidence interval (CI). Effect 
sizes (ES) were calculated using Cohen’s d, with an ES of <0.2 considered trivial, 
>0.2 small, >0.6 moderate, >1.2 large and > 2.0 very large (Hopkins, 1997). The 
effect was deemed unclear if its 90% confidence interval overlapped the 
thresholds for small positive and negative effects. The thresholds used to 
determine small positive and negative effects were and effect size of 0.2, or, 
where known, the value of the smallest worthwhile change (e.g. 0.3 of the CV = 
0.81% for mean power) (Hopkins, 2006; Hopkins & Batterham, 2006).  
 
Results 
 
Time-trial performance 
Power output in the 4PT was 2.3 ±4.8% (Δ mean ±90% CI) greater in the KET (364 
± 58 W) vs. PLA trial (355 ± 46 W) (Figure 4; Table 2). This result was associated 
with an unclear effect on performance when using 0.81% as the smallest 
worthwhile change.   
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Blood measures 
Blood measured variables are shown in Table 2 and Figure 4. The ketone 
supplement (KET) trial revealed a three-fold increase in BHB levels (0.2 to 0.6 
mmol/L) over the duration of the trial. Average baseline BHB concentrations for 
both trials were 0.2 ± 0.1 mmol/L (mean ± SD), however the ketone supplement 
increased blood BHB concentrations at a greater rate during exercise, resulting in 
a 157% ±63% compared to the PLA (Δ mean ± 90% CI; ES = 3.02 ±0.8; very large). 
Average blood lactate concentrations increased after both the submaximal (1.8 ± 
0.7 mmol/L vs 1.6 ± 0.5 mmol/L for KET vs PLA) and 4PT (8.8 ± 3.2 mmol/L vs 7.6 
± 1.7 mmol/L for KET vs PLA respectively) exercise phases for the ketone trial but 
was unclear between conditions. Mean blood glucose concentrations at baseline 
were similar between trials (5.2 ± 1.7 mmol/L vs 5.4 ± 1.2 mmol/L for KET vs PLA; 
unclear). Average blood glucose during submaximal exercise was similar during 
the KET trial (0 min: 4.8 ± 0.7 mmol/L, 30 min: 4.4 ± 0.7 mmol/L, 60 min: 4.3 ± 0.6 
mmol/L, 90 min: 4.1 ± 0.7 mmol/L) compared to PLA (0 min: 4.8 ± 0.7 mmol/L, 30 
min: 4.4 ± 0.7 mmol/L, 60 min: 4.3 ± 0.6 mmol/L, 90 min: 4.1 ± 0.7 mmol/L) and 
between trial analysis was unclear. Blood glucose concentrations following the 
4PT were also similar and unclear between trials (4.6 ± 0.9 mmol/L vs 4.6 ± 1.2 
mmol/L for KET vs PLA, respectively). 
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Figure 4. Key performance and physiological markers during the placebo (PLA) and 
ketone supplement (KET) trails. 
The figure displayed represents average power at 30, 60, 90 min and following 4PT. β-
hydroxybutyrate measurements were taken at baseline (20 min prior to exercise), 0, 30, 
60, 90 min and after the 4PT. Both VO2 and RER analysis take from 0-10 min, 25-30 min, 
55-60 min, 85-90 min and during the 4PT. Error bars represent raw values as 90% CI. In 
terms of ES difference: *=Small ES, **=Moderate ES, ***=Large ES, ****= Very large ES. 
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Table 2. Values for the performance data and blood measure variables in the Placebo (PLA) and Ketone supplement (KET) trials 
 
PLA 
Mean ± SD 
KET 
Mean ± SD 
KET–PLA % ±90% CI 
effect size ±90% CI 
Mean Power (W) 355 ± 46 364 ± 58 
2.3 ±4.8  
ES = 0.16 ±0.3 
Unclear 
4PT BHB levels* 
(mmol/L) 
0.3 ± 0.3 0.6 ± 0.2 
157 ±63 
ES = 3.02 ±0.8 
Very Large 
Submaximal BHB levels** 
(mmol/L) 
0.3 ± 0.3 0.6 ± 0.3 
184 ±108 
ES = 1.55 ±0.6 
Large 
4PT GLU levels* 
(mmol/L) 
4.6 ± 1.2 4.6 ± 0.9 
3.7 ±13.8 
ES = 0.17 ±0.6 
Unclear 
Submaximal GLU levels** 
(mmol/L) 
4.3 ± 0.8 4.19 ± 0.7 
-3.7 ±6.5 
ES = -0.21 ±0.4 
Unclear 
4PT lactate levels* 
(mmol/L) 
7.6 ± 1.7 8.8 ± 3.2 
9.7 ±29.0 
ES = 0.37 ±1.1 
Unclear 
Submaximal lactate levels** 
(mmol/L) 
1.6 ± 0.5 1.8 ± 0.7 
6.7 ±26.0 
ES = 0.19 ±0.7 
Unclear 
* = taken immediately post 4PT. ** = taken immediately post submaximal exercise bout (90min). Abbreviations: 4PT= 4 min performance test; 
BHB= β-hydroxybutyrate; GLU= glucose. 
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Gas exchange (table 3) 
Mean RER was 2.2 ±1.9% higher in the KET (0.87 ± 0.05) compared to PLA trial 
(0.85 ± 0.03) during the 90 min submaximal exercise phase (ES ±90%CI = 0.51 
±0.4; moderate). Likewise, mean RER during the 4PT (1.01 ± 0.07 vs 0.96 ± 0.05 
for KET vs. PLA, respectively) was 4.3 ±3.3% greater in the KET compared to PLA 
trial (ES = 0.75 ±0.6; moderate). Average VO2 was lower in the KET compared to 
the PLA trial during the submaximal phase (3.19 ± 0.35 vs. 3.26 ± 0.33 L/min; 
2.3% ±4.4%), but this difference was unclear. VO2 was slightly increased (3.99 ± 
0.49 vs 3.88 ± 0.35 for KET vs PLA) in the KET vs. PLA trial during the 4PT (ES = 
0.24 ±0.3; small).  
 
Perception 
Ratings of perceived exertion was not substantially different between trials (13 ± 
1 PLA, 13 ± 1; ES = -0.12 ±0.3; unclear). 
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Table 3. Values for the measured metabolic variables in the placebo (PLA) and ketone supplement (KET) trials 
 
 
PLA 
Mean ± SD 
KET 
Mean ± SD 
PLA–KET, % ±90% CI 
effect size ±90% CI 
4PT RER 0.96 ± 0.05 1.01 ± 0.07 
4.3 ±3.3 
ES = 0.75 ±0.6 
Moderate 
Submaximal RER* 0.85 ± 0.03 0.87 ± 0.05 
2.2 ±1.9 
ES = 0.51 ±0.4 
Moderate 
4PT VO2 
(L/min) 
3.88 ± 0.35 3.99 ± 0.49 
2.4 ± 3.3 
ES = 0.24 ±0.3 
Small 
Submaximal VO2** 
(L/min) 
3.26 ± 0.33 3.19 ± 0.35 
-2.3 ±4.4 
ES = -0.21 ±0.4 
Unclear 
*= average taken from the 85-90 min gas sample. **= average across all gas samples during the sub maximal bout. Abbreviations: 4PT= 4 min 
performance test; BHB= β-hydroxybutyrate. 
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Discussion 
 
To our knowledge, this is the first study to examine the effects of an oral ketone 
supplement on exercise performance. The main finding was that acute oral 
ketone supplementation had an unclear effect on 4 minute all-out cycling 
performance, despite altering some of the physiological markers. However, 
ketone supplementation resulted in very large increases in blood BHB 
concentrations as well as a moderate increase in RER.  
A possible reason for the unclear effect on 4 minute all-out cycling performance 
may be due to the need for higher blood ketone levels than what was achieved 
in the current study. BHB values above 2mmol/L have been reported in humans 
without side effects using a ketone ester (Clarke et al., 2012). Average blood BHB 
concentrations  in the current study (0.63 mmol/L) peaked far below the levels 
described by Hashim and VanItallie (2014) to induce therapeutic ketosis (≥2 
mmol/L). These higher blood ketone concentrations will result in the body 
utilising a greater proportion of BHB as fuel compared to glucose. There may also 
be possible advantages of ingesting glucose alongside ketones which has been 
shown to further increase hydraulic efficiency in the rat heart  than ketones 
alone (Sato et al., 1995). Sato et al. (1995) demonstrated that the addition of 
ketone bodies (4 mmol/L BHB plus 1 mmol/L acetoacetate) to 10 mmol/L of 
glucose increased hydraulic work of the heart by ~25%, while the combination of 
insulin and ketones to the glucose increased efficiency by ~36% (Sato et al., 
1995). The finding suggests that the inclusion of CHO into the ingested formula 
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may enhance the utilisation of ketone bodies and yield an opportunity to further 
increase exercise performance. 
The increased RER, which coincided with the increased BHB concentrations 
during submaximal exercise, was in stark contrast to previous research resulting 
in similar blood ketone levels after adaptation to a ketogenic diet (Lambert et al., 
2001; Phinney et al., 1980; Zajac et al., 2014). Phinney et al. (1980) demonstrated 
lower RER values during exercise following a ketogenic diet (RER = < 0.70) for 6 
weeks compared to a pre-diet control (RER = 0.76). The different findings 
highlighted in the current study may be explained by the metabolism of 
exogenous ketones compared with endogenously produced ketones (Cox & 
Clarke, 2014). The creation of ketones via ketogenesis are due to the breakdown 
of adipose tissue to produce energy (Laffel, 1999). In contrast, supplements 
provide ‘free’ ketone bodies that are easily metabolised in the gut. Therefore the 
likely reason for the higher RER observed in our study may be because ketones, 
following oxidation, resemble the glucose RER output more so than fat 
(acetoacetate = 1.0, BHB= 0.89, acetone =1.0) (Frayn, 1983). These higher RER 
values may also suggest that ketones were oxidised in preference to available 
glucose. Indeed, ketone bodies are thought to act as signals limiting glucose and 
glycogen metabolism. This in turn spares glycogen for during high intensity 
exercise when it is needed (Cahill Jr, 1976; Robinson & Williamson, 1980). The 
higher RER, VO2 and power output during the 4PT phase in the ketone trial in the 
current study supports this possibility. 
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The current study found a small increase in VO2 during the 4PT as well as an 
unclear reduction in VO2 during the submaximal exercise phase in the ketone 
trial compared to the placebo trial. Our results differed slightly from work by 
Sato et al. (1995) who demonstrated the efficiency of ketones compared to 
glucose in rats by showing a reduction amount of oxygen consumed (VO2) during 
exercise at a fixed intensity. Therefore, we would have expected to see a clear 
decrease in oxygen consumption over the submaximal bout (Kashiwaya et al., 
1994; Sato et al., 1995; Veech et al., 2001); however our finding was unclear. As 
discussed prior, blood ketone concentrations may not have been high enough to 
see a substantial change in submaximal VO2.  
It has been previously suggested that ketones are carried by the same 
monocarboxylate transporters (MCT) as lactate and therefore it is likely that 
well-trained athletes have already made the adaptations needed to utilise 
ketones at a greater rate (Pilegaard et al., 1999). For this reason an athlete who 
is able to exercise at higher rates of glycolysis should see greater performance 
benefits due to their ability to transport ketones across cell membranes at 
greater rates to be metabolized elsewhere (Halestrap & Wilson, 2012; Pilegaard 
et al., 1999). We can therefore postulate that well-trained athletes will have a 
greater improvement using ketone supplements than those who are less trained. 
In our study the two cyclists who were considered to be the most highly trained 
(as measured through VO2peak and competition status), showed the greatest 
performance improvement - increasing power output by 15% and 19% 
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respectively. Pilegaard et al. (1999) had made similar observations when 
comparing the responses of highly trained vs lesser trained individuals. 
Future research should explore the synergistic effects of carbohydrate and its 
effect on the utilisation of ketone bodies. Longer performance tests are also 
more likely to demonstrate worthwhile changes in exercise performance due to 
the potential glycogen sparing ability of ketones  (Robinson & Williamson, 1980). 
It is also advised that future work should look to provide an equal calorie placebo 
so that comparisons can be made between energy sources to mimic real world 
athletic practices during racing situations. New research should also look to make 
comparisons between well-trained vs untrained populations and look at the 
individual variation found in this research.  
In conclusion, the present study has shown that ketone supplementation 
increased blood BHB concentrations, but had an unclear effect on 4-minute 
cycling performance in highly-trained cyclists. These findings were attained 
alongside an increase in RER values during the entire exercise bout and an 
increase in average VO2 during the 4-minute performance test.  
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Chapter 3:  
Study 2: The effects of acute ketone 
supplementation on cognitive function. 
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Abstract 
Ketone supplements have been shown to improve cognitive performance in 
those suffering from states of neurological disease. However, research is yet to 
evaluate the effect that these supplements have on cognitive performance in 
healthy populations. The present single blind, placebo-controlled study 
examined the use of an oral ketone supplement on cognitive performance in 40 
recreational athletes (22 male/18 female; mean ± SD: age; 30 ± 10 y). Individuals 
were randomly allocated into either the placebo (PLA, n=20) or ketone 
supplement (KET, n=20) group. Cognitive function was assessed through five 
tests designed to assess different components of neuro-muscular performance, 
reaction time, processing speed and memory recall; finger tap test (FTT), stroop 
test (ST), reaction time test (RT), monkey-ladder test (MLT) and one-card test 
(OCT), where test-retest reliability for each test was also assessed. No statistically 
significant differences (p > 0.05) were observed in cognitive function between 
groups. Effect size (ES) analysis revealed small improvements in the KET trial for 
ST (ES ±90%CI= 0.34 ±0.40) as well as the MLT (ES ±90%CI= 0.34 ±0.40) with 
either trivial or unclear results for FTT, RT and OCT when compared to PLA. Three 
of the five tests resulted in an acceptable test-retest reliability (< or ~10% CV). It 
is concluded that acute ketone supplementation has a limited effect on the 
cognitive performance tests used in the current study when performed by 
recreational athletes. 
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Introduction 
For elite athletes, improvements in physical performance can be difficult to 
attain, therefore scientists and coaches are starting to recognise the importance 
that the neuromuscular system plays on athletic performance. For these athletes 
the ability to be able to make quick, accurate decisions may be the difference 
between first and second place. Consequently, athletes participating in many 
different sports look towards the use of ergogenic aids to facilitate mental 
alertness and subsequent athletic performances (Tokish, Kocher, & Hawkins, 
2004). The ideas behind these ergogenic aids are to improve brain processing 
speeds, reaction time, neuromuscular performance, decision making and 
memory recall, in the hope of gaining an advantage over their competitors 
(Baker, Nuccio, & Jeukendrup, 2014).  Anecdotally, the use of ketone 
supplements has been described by many to increase alertness and provide a 
stimulant-like effect on the body (Brown, 2007). Such claims are currently 
untested, although improvements have been reported in cognitive function for 
those suffering from various disease states (Paoli et al., 2013). 
There is a plethora of research on the therapeutic benefits of ketones, many of 
which promote the ability of ketones to improve functions of the nervous system 
and improve certain metabolic disorders (D'Agostino et al., 2013; Masino et al., 
2009; Paoli et al., 2013; Seyfried, 2014; Veech, 2004; Veech et al., 2001). 
Research has shown an elevation in blood ketone levels to enhance cognitive 
performance in those suffering from  Parkinson’s disease (Vanitallie et al., 2005), 
Alzheimer’s disease  (Krikorian et al., 2012; Reger et al., 2004) and epilepsy  (Levy 
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et al., 2012). Using an emulsified MTri to elevate blood ketone levels, Reger et al. 
(2004) reported that an increase in cognitive function was associated with higher 
ketone values (p = 0.02) in memory impaired adults. Similarly Krikorian et al. 
(2012), using a diet that induced ketosis, it was found ketone levels were 
positively correlated with memory performance (r = 0.45, p = 0.04) in those with 
mild cognitive impairment.  These findings from studies support the concept that 
ketones may offer a broad-range of neuro-protective benefits. Such research 
merits attention for ketones as a therapeutic option for neuro-muscular and 
cognitive performance. 
While attention has been given to the effects of ketones on cognitive 
performance, little is known about the mechanisms responsible for the 
improvements in cognitive function.  Page et al. (2009)  put forward the idea that 
β-hydroxybutyrates ability to support synaptic load may be of importance due to 
the fact that synapse activity is necessary to produce complex behaviours and 
store memories, accordingly a reduction in synapse activity has detrimental 
effects on cognition (Mayford et al., 2012; Tampellini et al., 2010).  
Ketones have also been shown to have neuro-protective properties although the 
mechanisms for the protection need further research (Gasior, Rogawski, & 
Hartman, 2006; Guzmán & Blázquez, 2004; Maalouf, Rho, & Mattson, 2009). The 
ability of neurons to resist metabolic stress may be a larger mitochondrial load 
and a more energy-efficient fuel (Sato et al., 1995). In combination, these factors 
may account for the enhanced ability of neurons to withstand metabolic 
challenges above what would ordinarily be beyond the resilience of the neurons 
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and result in cellular death. Another theory for improved cognitive function 
comes from the enhancement of gene expression that encodes mitochondrial 
enzymes and energy metabolism in the hippocampus, a part of the brain 
important for learning and memory (Noh et al., 2004).  
In essence there is confounding evidence towards the cognitive sparing ability of 
ketones in those suffering from neurodegenerative disease; however it is yet to 
be demonstrated whether improvements can be seen in healthy recreational 
athletes. Numerous athletes have made the switch to ketogenic diets - low in 
carbohydrate and high in fat – in an attempt to elevate blood ketone 
concentrations and improve performance (Paoli, Bianco, & Grimaldi, 2015). The 
exact mechanisms for improved performance when following a ketogenic diet 
are unknown. Many believe the advantages of a ketogenic diet are due to the 
metabolic efficiency of ketones, and the ability of the diet to reduce 
inflammation (Cameron-Smith et al., 2003; Forsythe et al., 2008; Lambert et al., 
2001; Sato et al., 1995). It is yet to be researched whether an elevation of ketone 
concentration via a ketogenic diet has the ability to improve cognitive function 
and therefore enhance sporting performance via improvements in cognitive 
performance. 
Research showing improvements in cognitive performance has led to the 
development of products to elevate ketone levels. Means of increasing ketone 
levels include ketogenic diets, coconut oils, medium chain triglyceride oils and 
more recently, the production laboratory produced ketones, in the form of 
esters and salts. The purpose of the current study was to investigate the effect of 
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an oral ketone supplement (β-hydroxybutyrate in sodium and potassium form) 
on different measures of cognitive performance in healthy individuals. 
 
 
Methods 
 
Participants 
40 recreational athletes volunteered for the current study (18 female, 22 male; 
mean ± SD: age; 30 ± 10 y). Following an explanation of all procedures, risks and 
benefits, each subject gave their written consent to participate in the study. 
Research was approved by the Institutions Human Research Ethics Committee. 
 
Experimental design 
The study implemented a single blind, placebo controlled, parallel group design 
whereby participants were randomly assigned to one of two conditions; placebo 
(PLA, n = 20) or a ketone supplement (KET, n = 20) trial. As part of the study, 
participants were required to attend the laboratory on a single occasion 
following a two hour fast. A requirement for those taking part was that they 
could not have taken any other nutritional supplement within one week of 
participating in the study. Participants were also required to refrain from 
strenuous activity (< 1 hour) or nutritional supplements (e.g. caffeine) considered 
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as potential ergogenic aids (< 12 hours) prior to the test. All experimental trials 
were conducted between the hours of 1300 and 1700 to limit the performance 
fluctuations caused by the time of day and influence of circadian rhythms 
(Blatter & Cajochen, 2007; Schmidt, Collette, Cajochen, & Peigneux, 2007).  
 
Familiarisation/Reliability 
To ensure that there was no learning effect during the experimental trial, 
participants performed four familiarisation trials of each test prior to the 
baseline trial. Each familiarisation trial was separated by ~3 minutes. Data from 
the familiarisation trials were collected in a subset of the population (n=30) to 
inform the test-retest reliability of each test in healthy participants. 
 
Experimental trial 
Following the familiarisation trials (~10 minutes), participants undertook baseline 
measures for all five of the cognitive tests. Upon ingesting either the ketone or 
placebo supplement, participants remained in a quiet, seated position for 45-
minutes before the post-testing took place. Participants were not permitted to 
perform any physically or mentally challenging tasks during this time. The 45-
minute period was implemented as it has been suggested that this is the optimal 
duration required for blood ketone levels to peak when using a similar dose of 
ketone supplements as the current study (D'Agostino, Arnold, & Kesl, 2014). The 
KET and PLA supplements were as follows: 
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KET: 30 ml of Ketoforce (Prototype Nutrition, IL, USA) diluted with 100 ml of 
sugar-free lemonade (The Coca-Cola Company, GA, USA). 
PLA: 3 g of table salt (NaCL) diluted with 100 ml of sugar-free lemonade (The 
Coca-Cola Company, GA, USA). 
 
Cognitive tests 
The cognitive tests selected for the current study included five separate 
measures to assess neuromuscular performance, memory, reaction time, and 
brain processing speed. Tests were conducted on two hand-held computer 
tablets (Apple Inc., CA, USA; Samsung, South Korea). The following tests were 
used: 
 
Finger Tap test (FTT) 
The FTT is designed to assess simple motor speed and manual dexterity. The test 
is typically administered as part of a neurological or neuropsychological 
assessment and has been implemented in numerous scientific literatures 
(Carlier, Dumont, Beau, & Michel, 1993; Schear & Sato, 1989; Schmitt, 2013). The 
test required participant to rest the palm of their dominant hand beside the 
computer tablet and tap the screen as many times as possible in 10 seconds.  
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Stroop Test (ST) 
The ST has been used widely in previous research because of its ability to assess 
cognitive flexibility, information processing speed, executive abilities and 
selective attention (Spooner & Pachana, 2006). The test required participants to 
indicate the colour of the font in the words ‘RED’ or ‘GREEN’ which can be 
written in either red or green font. The idea of the test was to correctly match 
the correct font colour with the corresponding word as many times as possible in 
60-seconds. If the participant correctly matched the colour, then a point was 
scored, conversely a point deducted for an incorrect match. The ST test has been 
previously validated as a reliable tool for cognitive performance (Bajaj et al., 
2014). 
 
Reaction time test (RT) 
The RT used a simple test whereby there was only one stimulus and one 
response. It required participants to tap the screen of the tablet as quickly as 
possible upon a change in colour from red to green. Each assessment consisted 
of five reaction tests and the median score was taken. RT tests have been 
validated as an accurate assessment of cognitive function (p < 0.001) in healthy 
adults (Jakobsen, Sorensen, Rask, Jensen, & Kondrup, 2011). 
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Monkey-ladder test (MLT) 
The MLT is used to assess short-term working memory. Also named the ‘limited-
hold memory task’ test, it stems from research where monkeys out-performed 
humans (Inoue & Matsuzawa, 2007). The test displayed a 5 x 5 grid containing 
several squares placed randomly around the screen. Initially these small blocks 
appear numbered (for 3 seconds). The numbers are then removed but the blocks 
remain in the same place. Participants must then click the blocks in the order 
that the numbers were displayed. The test will end when a participant makes 
three errors (wrong order) and the score given equates to the last level 
completed correctly.  
 
One card learning test (OLT) 
The OLT is another assessment designed to assess visual learning through a 
pattern separation model, which is part of the short-term memory function 
(Yassa et al., 2010). Theoretical models of pattern separation specify that 
information is organised in orthogonal and distinct non-overlapping 
representations so that that new memories can be stored quickly without 
interference (Norman & O'Reilly, 2003). A number of cards are revealed on the 
tablet screen whereby the subject must decide whether the card has been 
shown before and they respond by pressing “Yes” or “No”. The assessment 
displays a total of 21 playing cards. Scores range from 21 (100% correct answers) 
to 0 (0% correct answers). 
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Statistical analysis 
All data are reported as mean ± SD unless otherwise stated. The reliability data 
for each cognitive test were log-transformed and analysed using an Excel 
spreadsheet for reliability (Hopkins, Schabort, & Hawley, 2001). An individual’s 
coefficient of variation (CV) was calculated as the SD of an individual’s repeated 
measurement expressed as a percentage of his or her individual mean test score 
(Hopkins, 2000). Typical error is expressed as a CV% and as an absolute value 
along with upper and lower 90% confidence intervals (CI). An independent 
samples t-test was performed to examine the difference between KET and PLA 
trials for each test, with statistical significance set at p < 0.05 for all analyses. 
Effect sizes (ES) were calculated using Cohen’s d, and were interpreted using 
thresholds of 0.2, 0.6, 1.2 and > 2.0 for small, moderate, large and very large, 
respectively (Hopkins 1997). An ES of 0.2 was considered the smallest 
worthwhile positive effect and an effect size of < 0.2 considered trivial. The 
effect was deemed unclear if its confidence interval overlapped the thresholds 
for small positive and negative effects (Hopkins, 2006). 
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Table 4. Reliability of cognitive assessments reported as typical error of measurement (TEM) and coefficient of variation % (CV) for each test. Data 
reported as means (90% Confidence Interval). Highlighted values represent the lowest TEM and CV for each test. 
 FTT ST RT (ms) MLT (level) OCT 
TEM 2-1 
2.7 (2.3-3.5) 
4.8 (4.0-6.1) 25.6 (21.3-32.3) 1.1 (0.9-1.4) 1.4 (1.1-1.7) 
TEM 3-2 3.5 (2.9-4.6) 4.4 (3.7-5.6) 29.6 (24.1-38.8) 1.0 (0.8-1.3) 1.7 (1.4-2.2) 
TEM 4-3 2.4 (1.9-3.1) 3.2 (2.6-4.1) 23.4 (19.0-30.9) 0.9 (0.7-1.2) 1.7 (1.4-2.3) 
Mean TEM 2.9 (2.5-3.6) 4.2 (3.7-5.1) 26.3 (22.9-31.5) 1.0 (0.8-1.2) 1.6 (1.4-1.9) 
CV 2-1 3.6 (3.0-4.6) 60.7 (48.4-82.0) 9.1 (7.5-11.6) 20.6 (16.6-27.4) 9.0 (7.4-11.5) 
CV 3-2 4.6 (3.8-6.1) 31.7 (25.3-43.1) 11.1 (8.8-15.1) 21.3 (16.3-31.0) 11.8 (9.6-15.7) 
CV 4-3 4.6 (3.7-6.1) 11.4 (9.1-15.4) 9.3 (7.4-12.9) 19.1 (14.6-28.1) 12.3 (9.8-16.9) 
Mean CV 4.3 (3.7-5.2) 40.7 (34.3-50.4) 9.8 (8.4-11.9) 20.4 (17.2-25.6) 10.9 (9.3-13.5) 
2-1, represents the reliability between tests one and two. 3-2, represents the reliability between tests two and three. 4-3 represents the reliability between tests 3 and 4. 
The lowest TEM’s are identified by a shaded box. 
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Results 
 
Reliability 
The reliability of the cognitive assessments used in this study is presented in 
Table 4. The lowest typical errors of measurement were between tests 3 and 4 
for the FTT, ST, RT, and MLT. From these results it is evident that these tests 
involve a learning effect. Only the OCT differed, where the lowest typical error of 
measurement (mean ±90CI: 1.4 ±1.2 cards) was between tests 1 and 2. Apart 
from the ST and MLT, other assessments showed acceptable levels of reliability 
(< or ~10% CV). 
 
Cognitive function 
There were no statistically significant improvements in cognitive performance 
following the KET trial (p < 0.05) when compared to PLA (Table 5 and Figure 5). 
Cohen’s effect size analysis revealed a small improvement in the ST (mean ±90CI: 
-0.3 ±3.1; ES = 0.34 ±0.40) and MLT (0.5 ±0.6; ES = 0.34 ±0.40) for the KET trial, 
however these were the least reliable tests with the smallest CV being 11.4% and 
19.1% for the ST and MLT, respectively. The FTT score improved in the KET trial 
compared to the PLA trial by an average of 0.9 ±2.7 taps (ES = 0.09 ±0.26; trivial). 
The difference between groups for the OCT and RT were deemed unclear. 
  
 
5
7
 
 
Table 5. Pre- and Post- test scores for each group (KET and PLA – mean ± SD), with between group differences (mean ±90% confidence interval), 
statistical significance and effect size (ES). 
 KET PLA    
Test score Pre Post Pre Post 
Δ KET- PLA 
(Mean ±90% CI) 
P-value 
Effect  Size 
(ES ±90% CI) 
FTT 77.0 ± 8.5 78.9 ± 6.8 77.8 ± 11.4 78.8 ± 11.9 0.9 ±2.7 0.57 
0.11 ±0.3 
Trivial 
ST 26.7 ± 12.1 26.7 ± 8.4 29.7 ± 11.5 30.0 ± 13.7 -0.3 ±3.1 
 
0.87 
 
0.34 ± 0.4 
Small 
RT (ms) 264.3 ± 39.8 267.5 ± 48.8 265.8 ± 33.0 264.0 ± 27.6 5.0 ±12.5 0.51 
0.09 ± 0.4 
Unclear 
MLT (level) 6.2 ± 1.6 6.4 ± 1.6 6.6 ± 1.23 6.3 ± 1.45 0.5 ±0.6 
 
0.20 
 
0.34 ±0.4 
Small 
OCT 15.3 ± 3.9 15.4 ± 2.4 16.9 ± 1.7 16.9 ± 2.2 0.1 ±1.3 0.95 
0.20 ±0.5 
Unclear 
Abbreviations: finger tap test (FTT), stroop test (ST), reaction time test (RT), monkey-ladder test (MLT) and one-card test (OCT). 
  
 
58 
 
* 
* 
Figure 5. Average pre- and post- cognitive test scores for the ketone supplement (KET) trial vs 
placebo (PLA). 
Error bars represent 90% confidence intervals (CI). FTT = Finger Tap Test, ST = Stroop Test, RT = 
Reaction Time Test, MLT = Monkey ladder test, OCT = One card learning test. * represents a small 
Effect Size. 
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Discussion 
 
To the best of our knowledge the present study is the first to investigate the use 
of an acute oral ketone supplementation on cognitive function in healthy 
individuals. Our findings suggest that an acute ketone supplement has little 
effect on cognitive performance for healthy recreational athletes. Results for the 
current study showed small but not statistically significant improvements in both 
the ST and MLT, however, these two tests were shown to be the least reliable 
measures of cognitive performance according to our test-retest reliability 
analysis. The other assessments were deemed to have either trivial or unclear 
effects between the two groups. 
Opposing our findings, prior research by Krikorian et al. (2012) and Reger et al. 
(2004) found higher ketone levels had a positive effect on cognitive performance 
(p = 0.04 and 0.02 respectively) for those suffering from memory impairment. An 
explanation for our findings to have differed from the above research may be 
because the tests used in our study were unable to place a large enough strain 
on the participants processing capabilities. Krikorian et al. (2012) believed that 
ketones may enhance the processing capacity when large cognitive loads are 
undertaken. Such a hypothesis could explain why healthy individuals did not 
improve cognitive performance after the KET trial. It is therefore presumed that 
the effects ketones demonstrate on those suffering from Alzheimer’s disease and 
mild cognitive impairment are greater due to the relatively larger cognitive load 
placed on these populations (Krikorian et al., 2012; Reger et al., 2004; Roberts & 
Besner, 2005). The participants in the present study were deemed healthy with a 
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comparatively young average age and no history of cognitive impairment. A 
further possibility may be due to the fact that some of the tests used in the 
current study may not have had sufficient reliability to account for the sensitive 
changes between the supplement and placebo.  
Further research should look to assess cognitive function during intense 
exercises bouts with the use of ketone supplements. Bough et al. (2006) 
discovered that consumption of a ketogenic diet may enhance the ability of 
neurons to resist metabolic stress via two factors: a larger mitochondrial load - 
through its ability to stimulate mitochondrial biogenesis - and a more energy-
efficient fuel. Therefore a combination of these factors may account for the 
enhanced ability of neurons to withstand metabolic challenges (Bough et al., 
2006). The exhaustive nature of exercise may increase the cognitive load in 
healthy individuals, allowing for a greater need to improve cognitive function. 
Alongside an increase in cognitive load, the lower requirement for oxygen during 
exercise when ketones are used as a fuel suggests that the supplement may yet 
improve the accuracy of decision making in sporting scenarios (Sato et al., 1995; 
Veech, 2004).  
The average ketone levels described by Hashim and VanItallie (2014) to induce 
therapeutic ketosis are thought to be ≥2 mmol/L. A limitation of the current 
study is that blood ketone levels were not measured; therefore we cannot be 
certain that the supplement altered blood ketone concentrations and previous 
research suggests that the blood ketone concentrations would have peaked well 
below 2 mmol/L. Numerous means to elevate BHB concentrations now exist and 
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ketone esters may have the ability to elevate ketone levels beyond that of the 
ketone salt used in the current study. 
In conclusion our research showed that ketone supplementation did not improve 
cognitive function in a healthy, active population. A possible reason for the lack 
of significant findings in the current may be related to the relatively low cognitive 
load placed on our participant’s. The use of ketone supplements in healthy 
populations placed under high cognitive loads, such as that that occurs during 
intense exercise, warrants further research. 
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Chapter 4: 
Conclusion 
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Summary 
The two studies included in this thesis were designed to investigate an oral 
ketone supplement on measures of physiological, cognitive and exercise 
performance. The first study examined cycling performance following the 
ingestion of exogenous ketone supplements. The research found that ketone 
supplementation in highly-trained cyclists failed to show meaningful 
improvements in regards to performance. The ketone trial showed an unclear 
effect on power output (mean ±90%CI; 2.3 ±4.8%) during a 4-minute all out time-
trial compared to the placebo.  In regards to physiological markers, ketone 
supplementation increased blood BHB concentrations three-fold; subsequently 
increasing RER values by 2.2 ±1.9% during submaximal exercise compared to the 
placebo (ES = 0.51 ±0.4; moderate). During the 4-minute test, increases in both 
the average VO2 (2.4 ± 3.3%, ES = 0.24 ±0.3; small) and RER were evident (4.3 
±3.3%, ES = 0.75 ±0.6; moderate) in the ketone supplement trial compared to the 
placebo. These metabolic changes warrant the need for further research 
regarding the use of ketone supplementation for sparing glycogen and may have 
real world applications for sports such as road cycling, where intermittent bouts 
of intense exercise are dispersed amongst long periods of low-moderate 
intensity exercise. The second study conducted in Chapter Three found that 
ketone supplementation did not improve cognitive function in recreational 
athletes. Cognitive function was assessed through five tests designed to assess 
different components of neuro-muscular performance, reaction time, processing 
speed and memory recall; finger tap test (FTT), stroop test (ST), reaction time 
test (RT), monkey-ladder test (MLT) and one-card test (OCT), where test-retest 
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reliability for each test was also assessed. No statistically significant differences 
(p > 0.05) were observed in cognitive function between groups. Effect size (ES) 
analysis revealed small improvements in the KET trial for ST (ES = 0.34 ±0.4) as 
well as the MLT (ES = 0.34 ±0.4) with either trivial or unclear results for FTT, RT 
and OCT when compared to PLA. Whilst our study results differ from others that 
have conducted their research on individuals who suffer from either cognitive 
impairments or neurological disease, we put forward two possible reasons that 
may explain the opposing results. One is that the cognitive load placed on 
individuals was not enough to see substantial improvements following ingestion 
of the ketone supplement. The second is that the improvement in cognitive 
function for those with memory impairments and neurological disease stem from 
the mechanisms responsible for these disease states of which little is currently 
known.  
 
Practical applications 
 
The evidence from this research does not support the use of ketone 
supplementation as an ergogenic aid to facilitate peak athletic performances. 
Whilst the research demonstrated alterations in physiological markers, such as 
an increase in blood BHB concentrations, and an increase in RER, there currently 
stands no evidence to suggest ketone supplementation plays a role in improving 
athletic performance. To the best of our knowledge the research in this thesis is 
the first to assess the effects of an acute oral ketone supplementation on short-
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term, high-intensity cycling performance. Consequently the use of ketone 
supplementation to aid athletic performances of different durations and 
modalities should not be ruled out. Accordingly this research should act as a 
reference for future work in the area. The following recommendations are made 
for further studies: 
 
Future research 
Cycling performance 
 
 Carbohydrates may further enhance the ability of ketone 
supplementation due to their synergistic properties; future research 
should include a formula that combines synthetic ketones and 
carbohydrates. 
 Knowledge gaps remain plentiful in regards to a diet induced ketosis and 
further research using ketone supplements may facilitate our knowledge 
of endogenous ketones. However, for this to be effective, we must 
improve our understanding of the differences between exogenous and 
endogenous ketones regarding physiology and metabolism. Research in 
the field may improve the current strategies for utilising both 
endogenous and exogenous ketones for exercise performance. 
 Individual responses in our research varied; therefore further research 
should look to see whether training status has an impact on results. 
Future work should attempt to take into account the possibility of 
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responders and non-responders, and look to identify possible 
characteristics between these groups 
 Future research should aim to see whether there may be a dose-response 
relationship with ketone supplementation. 
 Ketone-esters may have the ability to elevate blood BHB concentrations 
higher than ketone salts (as used in the current study). Therefore 
research using ketone-esters may have a greater impact on exercise 
performance. 
 Much of the reported benefits of ketones for exercise performance are 
for ultra-endurance events due to their glycogen sparing ability. Future 
research should use longer performance tests to assess whether ketone 
supplementation can enhance performance for events longer in duration. 
Cognitive performance 
 
 Future work should look to conduct cognitive assessments in-between 
periods of high intensity exercise to assess whether ketones improve 
cognitive performance under conditions of hypoxia.  
 To assess cognitive function, future work should use tests that are greater 
in difficulty to the ones used in our research. It is thought that both the 
reliability of the tests used in our research and relatively low cognitive 
load that these tests placed on individuals were not high enough to see 
worthwhile changes in performance.  
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Appendix 1 - Research consent form - Effects of an oral ketone supplement on 
exercise metabolism and cycling performance 
 
Informed Consent form 
 
Project Title: Effect of acute ketone supplementation on cycling 
performance and metabolism. 
 
Principal Researchers: Shem Rodger, Dr. Matt Driller 
 
This is to certify that I,                                                   hereby agree to participate 
as a volunteer in a scientific investigation as an authorised part of the 
research program of the Waikato University Sport and Leisure Department 
under the supervision of                                        . 
 
The investigation and my part in the investigation have been defined and 
fully explained to me by                                             and I understand the 
explanation. A copy of the procedures of this investigation and a description 
of any risks and discomforts has been provided to me and has been discussed 
in detail with me. 
 
● I have been given an opportunity to ask whatever questions I may 
have had and all such questions and inquires have been answered to 
my satisfaction. 
 
● I understand that I am free to withdraw consent and to discontinue 
participation in the project or activity at any time, without 
disadvantage to myself. 
 
● I understand that I am free to withdraw my data up until the point of 
analysis without disadvantage to myself. 
 
● I understand that any data will remain anonymous with regard to my 
identity through a coding system. The data will be made publishable, 
so every effort will be made to ensure confidentiality, however this 
cannot be guaranteed. 
 
● I certify to the best of my knowledge and belief, I have no physical or 
mental illness or weakness that would increase the risk to me of 
participation in this investigation. 
 
● I am participating in this project of my (his/her) own free will and I 
have not been coerced in any way to participate. 
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Signature of Subject: ________________________________________             Date: 
____/____/____ 
 
 
I, the undersigned, was present when the study was explained to the 
subject/s in detail and to the best of my knowledge and belief it was 
understood. 
 
Signature of Researcher: ____________________________________              
Date:___/____/____ 
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Appendix 2 - Participant information sheet- Effects of an oral ketone 
supplement on exercise metabolism and cycling performance 
 
Participant Information: 
Dear participant, 
 
You are being invited to take part in a research study, which will help the 
Waikato University Sport and Leisure Department determine the effect that 
ketone supplements have on the cycling performance. Before you volunteer 
to take part in the study please take the time to read the following 
information carefully and if there is anything that is not clear or you would 
like more information, please feel free to contact us. 
 
Purpose 
The aim of the study is to determine the effects of ingesting ketones as an 
ergogenic aid for cycling performance. 
 
Significance 
 
Theory indicates that ingestion of ketone supplement may have the ability to 
mimic the metabolic adaptations of a ketogenic diet a topic of interest for 
many high level athletes. This study concentrates on a new and exciting 
nutritional supplement that may enhance performance. 
We will seek to answer the question of whether or not the use of such a 
supplement can alter an athlete’s performance or metabolism. The 
significance of such a study will provide an insight into the use of an 
exogenous ketone for athletes competing in events between the 4 to 8 minute 
ranges. 
To date, little is understood about the effect of ketone supplement on 
exercise performance. As such, the purpose of this study is to provide an 
insight into the supplements use prior to high-intensity exercise in well-
trained cyclists. 
 
 
Selection Criteria 
A total of 12 trained cyclists who can commit to three testing sessions will be 
selected. Participants will have to be healthy and have no contraindications 
to vigorous exercise.  
 
To be eligible in this study you must be: 
● Aged between 18 and 50 years 
● Have a VO2 max >60ml.kg-1.min-1 
 
And NOT have the following: 
● Injury, illness or health issue which would disrupt the subject’s 
performance eg. lower limb injury 
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● Injury, illness or health issue which would endanger the subjects 
health eg. heart condition 
If you meet all of these criteria then you can choose to participate in this 
research project.  
 
It is up to you to decide whether or not to take part.  If you do decide to take 
part you will be given this information sheet to keep and asked to sign a 
consent form.  If you decide to take part you are still free to withdraw at any 
time and without giving a reason 
 
Protocol 
 
Participants are required to attend the Waikato University laboratory at the 
Avantidrome in Cambridge on three separate occasions. One familiarisation 
session where a VO2max test will be conducted and a practice exercise trial 
will be completed. One week after the familiarisation session participants 
will undergo the first experimental session, with the second experimental 
session taking place at least 48 hours after the first trial. Each participant will 
conduct an exercise trial taking the placebo and ketone supplement. The 
outline of the experimental session is highlighted below.  
 
 
90 min VT2 
2 min recovery 
Maximal 4 min performance test 
 
 
What you will gain from participating in the study? 
As a participant, you will benefit from experience with the research process 
and gain knowledge about the area of research. You will be involved in 
innovative research, which will provide valuable information on sporting 
performance.  
 
 All information collected about you during the course of the research project 
will be kept strictly confidential.  You will be identified by a code number and 
all personal information will be kept private. Although all measures will be 
taken to preserve anonymity, this cannot be guaranteed 
 
 
Any inquiries regarding requirements and procedures used in this study are 
encouraged.  Please contact me if you have any questions. 
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Researcher Contact Details 
 
Shem Rodger 
Post-graduate student 
Waikato University, Sport and Leisure department. 
Mob: 0275024712 
Email: shemrodger@gmail.com 
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Appendix 3 - Research consent form - The effects of acute ketone 
supplementation on cognitive function 
Informed Consent form 
 
 
Project Title: The effect of ketone supplementation on cognitive 
performance. 
 
Principal Researchers: Nicole Bates, Jeremy Spence, Shem Rodger, Dr. Matt 
Driller. 
 
This is to certify that I,                                                   hereby agree to participate 
as a volunteer in a scientific investigation as an authorised part of the 
research program of the Waikato University School of Human Development 
and Movement Studies under the supervision of                                        . 
 
The investigation and my part in the investigation have been defined and 
fully explained to me by                                             and I understand the 
explanation. A copy of the procedures of this investigation and a description 
of any risks and discomforts has been provided to me and has been discussed 
in detail with me. 
 
● I have been given an opportunity to ask whatever questions I may 
have had and all such questions and inquires have been answered to 
my satisfaction. 
 
● I understand that I am free to withdraw consent and to discontinue 
participation in the project or activity at any time, without 
disadvantage to myself. 
 
● I understand that I am free to withdraw my data up until the point of 
recording without disadvantage to myself. 
 
● I understand that any data will remain anonymous with regard to my 
identity through a coding system. The data will be made publishable, 
so every effort will be made to ensure confidentiality, however this 
cannot be guaranteed. 
 
● I certify to the best of my knowledge and belief, I have no physical or 
mental illness or weakness that would increase the risk to me of 
participation in this investigation. 
 
● I am participating in this project of my (his/her) own free will and I 
have not been coerced in any way to participate. 
 
 
Signature of Subject: ________________________________________             Date: 
____/____/____ 
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I, the undersigned, was present when the study was explained to the 
subject/s in detail and to the best of my knowledge and belief it was 
understood. 
 
Signature of Researcher: ____________________________________              
Date:___/____/____ 
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Appendix 4 - Participant information sheet- The effects of acute ketone 
supplementation on cognitive function 
Participant Information: 
 
Dear participant, 
 
You are being invited to take part in a research study, which will help the 
University of Waikato Sport and Leisure Department determine the effect 
that ketone supplements have on cognitive function. Before you volunteer to 
take part in the study please take the time to read the following information 
carefully and if there is anything that is not clear or you would like more 
information, please feel free to contact us. 
 
Purpose 
The aim of the study is to determine the effects of ingesting a ketone 
supplement on cognitive function. 
 
Significance 
 
Numerous studies have indicated that elevated ketone levels have shown 
improvements in cognitive function in those suffering from mild cognitive 
impairments. To date, little is understood about the effect of ketone 
supplements on cognitive performance in healthy individuals although 
plethora of research has reported improvements in those suffering from 
neurodegenerative diseases such as Alzheimer’s. As such, the purpose of this 
study is to provide an insight into the supplements used to enhance cognitive 
performance. 
 
 
Selection Criteria 
40-50 healthy participants who can commit to one 1-hour session will be 
selected.  
 
To be eligible in this study you must be: 
● Aged between 18 and 50 years 
 
And NOT have the following: 
● Injury, illness or health issue which would disrupt the subject’s 
performance on an iPad with a touch screen. e.g. Injured finger, blind. 
 
If you meet all of these criteria then you can choose to participate in this 
research project.  
 
It is up to you to decide whether or not to take part.  If you do decide to take 
part you will be given this information sheet to keep and asked to sign a 
consent form.  If you decide to take part you are still free to withdraw at any 
time and without giving a reason 
 
  
 
92 
 
Protocol 
 
Participants are required to attend the University of Waikato laboratory at 
the Avantidrome in Cambridge on one occasion. At the beginning of this 
session three familiarisation trials will be conducted to ensure participants 
are aware of how the tests operate and minimise the possible learning 
effects. After this a baseline test is to be completed prior to ingesting the 
supplement. Upon ingesting the supplement, participants must wait 45 
minutes before repeating the same cognitive tests. Experimental trials will 
include a memory test, stroop test and reaction time test. These tests are to 
be completed on an iPad. 
 
 
What you will gain from participating in the study? 
As a participant, you will benefit from experience with the research process 
and gain knowledge about the area of research. You will be involved in 
innovative research that will provide valuable information on performance in 
regards to cognitive function.  
 
 All information collected about you during the course of the research project 
will be kept strictly confidential.  You will be identified by a code number and 
all personal information will be kept private. 
 
 
Any inquiries regarding requirements and procedures used in this study are 
encouraged.  Please contact any of us if you have any questions. 
 
Research Contact Details 
 
Dr. Matt Driller 
 
Nicole Bates 
 
Jeremy Spence Shem Rodger 
Senior Lecturer 
University of 
Waikato 
Mob: 
0272929029 
Email: 
mdriller@waikato.a
c.nz 
Post-graduate student 
University of Waikato 
Email: 
eb7@students.waikato.
ac.nz 
Post-graduate student 
University of Waikato 
Mob:  0212632770 
Email: 
jns9@students.waikato.
ac.nz 
Post-graduate 
student 
University of 
Waikato 
Mob: 0275024712 
Email: 
shemrodger@gmail.
com 
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Appendix 5 - Pre-Test Medical Questionnaire 
 
 
 
First Name/s __________________________________ Surname 
_________________________________ 
Date of Birth _____/______/_____    Gender (circle)  Male 
 Female 
Please answer the following questions by circling the appropriate response, or filling in the blank. 
1. How would you describe your present level of activity? 
Sedentary Moderately Active Active  Highly Active 
 
2. How would you describe your present level of fitness? 
Unfit  Moderately Fit  Trained  Highly Trained 
 
3. How would you consider your present body weight? 
Underweight Ideal   Slightly Over Very Overweight 
 
4. Smoking habits:  Are you currently a smoker?  Yes No 
How many do you smoke?   ……per day 
Are you a previous smoker?  Yes No 
How long is it since you stopped?  ……..years 
Were you an occasional smoker?  Yes No 
     ……per day 
Were you a regular smoker?  Yes No 
     ……per day 
5. Do you drink alcohol?      Yes No 
If you answered Yes, do you have? 
 
 An occasional drink  A drink everyday   More than 
one drink a day 
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6. Have you had to consult your doctor in the previous six months? 
If you have answered Yes, please give 
details………………………………………………………………………. 
……………………………………………………………………………………………………………
………………… 
 
7. Are you presently taking any form of medication? 
If you have answered Yes, please give 
details………………………………………………………………………. 
……………………………………………………………………………………………………………
………………… 
 
8. As far as you are aware, do you suffer from or have you ever suffered from?(circle if yes 
to any) 
 
a. Diabetes    b. Asthma 
c. Epilepsy    d. Bronchitis 
d. Any form of heart complaint*  e. Raynaud’s Disease 
f. Marfans Syndrome*   h. Aneurysm/embolism* 
i. Anaemia    j. Haemophilia* 
 
 
Please continue filling form over the page. 
 
 
9. *Is there a history of heart disease in your family?     Yes
 No 
10. *Do you currently have any form of muscle or joint injury?    Yes
 No 
11. Have you had to suspend your normal training in the previous two weeks?  Yes
 No 
12. Please read and answer the following questions:    
a. Are you suffering from any known serious infections?    Yes
 No 
b. Have you had jaundice within the previous year?     Yes
 No 
c. Have you ever had any form of hepatitis?      Yes
 No 
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d. Are you HIV antibody positive?       Yes
 No 
e. Have you ever been involved in intravenous drug use?    Yes
 No 
f. For females, are you currently, or in the previous 6 months, pregnant?  Yes
 No 
 
13. As far as you are aware, is there anything that might prevent you from successfully 
completing the tests that have been outlined to you? 
 
Consent of Athlete/Participant 
 
________________________   _____/______/_____ 
Athlete/Participant Signature                    Date  
 
_______________________________________ _________________________       
 ____/______/____ 
Guardian name (required if age less than 16 yrs) Athlete/Participant Signature Date 
 
_______________________________________ _________________________       
 ____/______/____ 
Witness name     Signature   Date 
 
 
  
If the answer to any of the above questions is yes then: 
a. Discuss with the clinic personal the nature of the issue 
b. Questions indicated by * allow your doctor to fill out the ‘Doctors Consent Form’ which will be provided 
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Appendix 6 - UOW laboratory informed consent form 
 
 
 
 
I (print name) ____________________________ consent to participate in physiological 
assessment on the following terms: 
 
1. I have read the Explanation of Physiological Assessment Procedures attached and have 
understood what I will be required to do. I have had the opportunity to ask questions and 
received satisfactory explanations about the assessment/s to be conducted. 
 
2. I understand that I will be undertaking physical exercise at or near the extent of my 
physical capacity and there is possible risk in the physical exercise at that level, such as 
episodes of transient light-headedness, fainting, abnormal blood pressure, chest 
discomfort. 
 
3. I understand that this may occur although the staff in this laboratory will take all proper 
care in the conduct of the assessment, and I fully assume that risk. 
 
4. I understand that I can withdraw my consent, freely and without prejudice, at any time 
before, during or after testing. 
 
5. I have told the person conducting the assessment of any illness or physical defect I have 
that may contribute to the level of that risk. 
 
6. I understand that the information obtained from the test will be treated confidentially with 
my right to privacy assured. However, the information may be used for statistical or 
scientific purposes with privacy retained.  
 
7. I release this laboratory and its employees from any liability for any injury or illness that I 
may experience during the assessment as well as any subsequent injury or illness that is 
connected to or to any extent influenced by the assessment. 
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8. I will indemnify this laboratory in respect to any liability it may incur in relation to any other 
person in connection with the assessment. 
 
9. I hereby agree that I will present myself for testing in a suitable condition and have abided 
by any requirements for diet and activity prescribed to me by laboratory staff. 
 
________________________   _____/______/_____ 
Athlete/Participant Signature                    Date  
 
_______________________________________ _________________________       
 ____/______/____ 
Guardian name (required if age less than 16 yrs) Athlete/Participant Signature Date 
 
_______________________________________ _________________________       
 ____/______/____ 
Witness name     Signature   Date 
 
From Australian Institute of Sport, 2013, Physiological tests for elite athletes, 2nd ed. (Champaign, IL: Human Kinetics). 
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Appendix 7 - Rate of perceived exertion scale 
 
Rate of Perceived Exertion Scale 
6   No Exertion at All 
7   Extremely Light 
8     
9   Very Light 
10     
11   Light 
12 
13   Somewhat Hard 
14     
15   Hard (Heavy) 
16 
17   Very Hard 
18     
19   Extremely Hard 
20   Maximal Exertion 
Borg, G.A., (1982). Physiological basis of physical exertion. Medicine and Science in Sport and Exercise, 14, p 377.  
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Appendix 8 - Ethics approval 
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Appendix 9 - Ethics approval 
 
 
